ANDREA GALLAGHER: Open Payments
NPI 1629669213 · FINDLAY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,642 in 103 payments from 13 companies in 2025. Trend: 2023 $805 · 2024 $620 · 2025 $1,642
Food & beverage: $1,642
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $385 |
| Madrigal Pharmaceuticals | 11 | $310 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $226 |
| Phathom Pharmaceuticals, Inc. | 14 | $168 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $146 |
| Ardelyx, Inc. | 5 | $112 |
| Regeneron Healthcare Solutions, Inc. | 4 | $68 |
| Janssen Biotech, Inc. | 3 | $56 |
| Aimmune Therapeutics, Inc. | 3 | $52 |
| GENZYME CORPORATION | 3 | $47 |
Products named: REZDIFFRA, ENTYVIO, VOQUEZNA, XIFAXAN, RINVOQ, SKYRIZI, DUPIXENT, IBSRELA.
Industry payments across OH — which companies pay providers there.
